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Surface plasmon resonance (SPR) optical ﬁber biosensors can be used as a cost-effective and relatively
simple-to-implement alternative to well established bulky prism conﬁgurations for high sensitivity
biological sample measurements. The miniaturized size and remote operation ability offer them a
multitude of opportunities for single-point sensing in hard-to-reach spaces, even possibly in vivo. The
biosensor conﬁguration reported in this work uses a tilted ﬁber Bragg grating (TFBG) in a commercial
single mode ﬁber coated with a nanometer scale silver ﬁlm. The key point is that by reducing the silver
ﬁlm thickness to around 20–30 nm (rather than 50 nm for optimal SPR excitation), different modes of the
TFBG spectrum present very high but opposite sensitivities to refractive index (RI) changes
around the TFBG. Experimental results obtained with the coated TFBG embedded inside a
microﬂuidic channel show an amplitude sensitivity greater than 8000 dB/RIU (Refractive Index Unit) and
a limit of detection of 105 RIU. Using this device, the effect of different concentrations of protein in rat
urine was clearly differentiated between healthy samples, nephropatic samples and samples
from individuals under treatment, with a protein concentration sensitivity of 5.5 dB/(mg/ml) and a limit
of detection of 1.5103 mg/ml. Those results show a clear relationship between protein
outﬂow and variations in the RI of the urine samples between 1.3400 and 1.3408, pointing the way to the
evaluation and development of new drugs for nephropathy treatments. The integration of
TFBGs with microﬂuidic channels enables precise measurement control over samples with sub-microliter
volumes and does not require accurate temperature control because of the elimination of the tem-
perature cross-sensitivity inherent in TFBG devices. Integration of the TFBG with a hypodermic needle on
the other hand would allow similar measurements in vivo. The proposed optical ﬁber/microﬂuidic
plasmonic biosensor represents an appealing solution for rapid, low consumption and highly sensitive
detection of analytes at low concentrations in medicine as well as in chemical and environmental
monitoring.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Human urine normally contains a few volume of protein that is
less than 150 mg per 24 h and it is hard to be identiﬁed by routine
tests. Proteinuria, deﬁned as urinary protein excretion greater than
300 mg per 24 h, is an important sign for renal damage and its
expression often precedes any detectable decline in renal ﬁltration
function. The increase of proteinuria accelerates kidney damageB.V. This is an open access article u
),and promotes the progression of chronic kidney disease (CKD) and
ﬁnally leads to end-stage renal disease (ESRD) (Ishani et al., 2006;
Tonelli et al., 2011). Previous studies identify that proteinuria is a
strong and independent predictor of the increased risk for cardi-
ovascular mortality in CKD patients with or without diabetes
(Agrawal et al., 2009; Matsushita et al., 2010). Therefore, early
diagnosis of proteinuria is essentially important for prevention
and treatment of chronic kidney disease and its complications.
Traditional methods to identify the small changes in urine due to
expression increasing of protein are conducted by detecting the
protein excretion. The most widely accepted formats of “wet-lab”
type analytic biochemistry assays are the Coomassie brilliant blue
protein assay (Chial et al., 1993) and the bicinchoninic acid assaynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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plemented using bulk optic laboratory instrumentation (like mi-
croplate array systems) in applications such as pharmaceutical
research where a large number of tests performed simultaneously
in parallel. However these methods are susceptible to environ-
mental interferences and suffer from time consuming sample
preparation (having to bring samples back to a laboratory and
label the sample for additional selection and ampliﬁcation). De-
signing new sensing techniques with detection levels and relia-
bility comparable to large laboratory instruments, but using label-
free methods in small scale point-of-care devices is an important
development in this ﬁeld.
The use of optical ﬁber devices as biomedical sensors presents
many well-known desirable features (size, cost, feasibility) for la-
bel-free methods as they contribute to the overall reduction in
costs and ease of use factors (Baldini et al., 2012; Wang and
Wolfbeis, 2013). Fiber optic sensors can be easily inserted into the
media to be sensed (instead of having to bring samples inside an
instrument) either as a hand held probe or as a set of remotely
operated devices along a ﬁber optic cable (in environmental
monitoring applications for instance). However, it should be noted
that for biochemical sensing ﬁelds, it is usually necessary to im-
prove the limit of detection (LOD) levels to at least 105 RIU (Re-
fractive Index Unit), by increasing the wavelength shift sensitivity
while keeping noise level down and spectral features narrow
(White and Fan, 2008). Fortunately, it has been recently demon-
strated that the addition of a nanometric-scale gold or silver
coating overlay on the optical ﬁber outer surface considerably
enhances the refractometric sensitivity through the generation of
surface plasmon resonance (SPR) (Homola, 2008; Piliarik and
Homola, 2009; Shalabney and Abdulhalim, 2011; Caucheteur et al.,
2015). The increased sensitivity achieved with plasmon waves
arises because of the large localization of electromagnetic energy
in the layer immediately adjacent to the metal surface. Any per-
turbation in that layer, such as the bonding of analytes on receptor
molecules modiﬁes the local refractive index (RI) of the dielectric
and the plasmon phase velocity. Meanwhile, in order to effectively
excite and accurately measure plasmon resonances and hence to
achieve this optimum sensitivity, a new kind of ﬁber grating, i.e.
the tilted ﬁber Bragg grating (TFBG, corresponds to a RI modula-
tion angled by a few degrees relative to the perpendicular to the
propagation axis) has been developed and well studied (Albert
et al., 2013; Guo et al., 2014, 2016; Thomas et al., 2012; CaucheteurFig. 1. Schematic of the pharmacological process of adriamycin nephropathy and ofet al., 2013). TFBGs beneﬁt from two unique features: the strong
polarization selectivity of the excited cladding modes (coming
from the breaking of the cylindrical symmetry of non-polariza-
tion-maintaining ﬁbers) and the high-density comb of narrow-
band spectral resonances (available to excite SPR over a wide range
of refractive indices and to measure their spectral location with
quality factors between 103 and 104). Therefore, SPR based TFBG
sensors open up a multitude of opportunities for single-point
biomedical sensing in hard-to-reach spaces, and offer an ex-
tremely improved LOD level to molecular interactions together
with very controllable cross-sensitivities (Voisin et al., 2014; Le-
pinay et al., 2014; Shevchenko et al., 2014).
It is the purpose of this paper to demonstrate the intrinsic re-
lationship between protein outﬂow (induced by adriamycin ne-
phropathy) and RI variation (over the range of 1.3400–1.3408 ap-
proximately) in urine by simply using an in-ﬁber based, label-free
direct detection device. This particular TFBG conﬁguration has
been optimized with an especially designed metal coating that
allows both SPR excitation and conventional evanescent ﬁeld
probing of the medium refractive index, thereby enabling a novel
differential data analysis method which increases the protein
concentration sensitivity of 5.5 dB/(mg/ml) and a limit of detection
of 1.5103 mg/ml over repeated measurement of rat urinary
samples with different concentration of protein. The detection
process was precisely controlled with a micro-ﬂuidic chip which
allows the measurement of μL-volumes of bio-sample solutions.
The proposed in-ﬁber plasmonic biosensor shows a minimal cross-
sensitivity to temperature (through referencing of the spectrum by
the core mode resonance) and its fabrication (UV-light grating-
inscription and surface nanometric-coating) does not impact the
structural integrity of the ﬁber so as to ensure the sensing stability
and reproducibility. Finally, our study on the relationship between
the outﬂow of protein and RI variation in urine will be helpful to
the understanding and evaluation of adriamycin nephropathy
(Okuda et al., 1986; Jeyaseelan et al., 2006).2. Materials and methods
2.1. Bio-samples preparation
The schematic of the pharmacological process of adriamycin
nephropathy and of the urine detection with a ﬁber-optic sensorthe urine detection with a ﬁber-optic sensor embedded in a microﬂuidic chip.
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Experimental animals: healthy male rats of speciﬁc pathogen
free level, age of 6–8 weeks, weight of 200720 g, and total
number of 30, are purchased from the experimental animal center
of Guangdong University of Chinese Medicine (Certiﬁcation No.
44005900000273). The rats were raised in SPF level animal rooms
(temperature of 22–25 °C, humidity of 40–70%). All the operations
are strictly executed in accordance with the experimental animal
agreement of the Chinese medicine academy committee.
Adriamycin: with a trade name of Doxorubicin, was purchased
from Shenzhen Main Luck Pharmaceuticals Inc., China.
ZhenWuTang medicine: a traditional Chinese prescription used
for adriamycin nephropathy treatment. It contains poria, herbac-
eous peony, rhizoma atractylodis macrocephalae, ginger and aco-
nite (with the proportion of 9:9:6:9:4). All of the above mentioned
Chinese herbs were processed by Guangdong Kangmei Pharma-
ceutical Inc., China.
Experimental process: all the rats were randomly divided into
three groups (10 rats for each group): (1) no adriamycin nephro-
pathy group (healthy group), in which the healthy rats were in-
jected with glucose saline (1 ml once) and then injected with
distilled water (1 ml/100 mg per day) for 4 weeks, this group is
used for comparison; (2) adriamycin nephropathy group (sick
group), in which the healthy rats were injected with adriamycin
(5 mg/kg once) and then injected with distilled water (1 ml/
100 mg per day) for 4 weeks; (3) Zhenwutang treatment group
(treated group), in which the healthy rats were injected with
adriamycin (5 mg/kg once) and then with ZhenWuTang medicine
(19 g/kg per day) for 4 weeks. After the completion of the above
process, the urine of the rats for each group were collected and
used for testing with our proposed plasmonic ﬁber-optic sensing
method. The traditional BCA method was also used on the same
samples for comparison.
2.2. Experimental setup and optical conﬁguration
The experimental setup requires the sensor to operate in the
transmission regime (Fig. 2). During the experiments, the 125 μm-
diameter sensors were ﬁxed in PDMS-based micro-ﬂuidicPCPolarizerBBS
Urinary samples
Healthy TreatedSick
Fig. 2. Schematic of ﬁber-optic sensing system: (a) urinary samples with different cochannels designed speciﬁcally for the biosensing tests (Guo et al.,
2014). While each individual sensor was ﬁxed in the micro-
channel (width 200 μm by height 150 μm) with help of UV-sen-
sitive adhesive on both sides of the sensing element, thus deli-
miting a length of 20 mm (for a total sensing volume of 35 μL,
taking into account the volume taken up by the ﬁber). Three
groups of urine sample solutions (Fig. 2a) corresponding to above
mentioned “no adriamycin nephropathy group (healthy group)”,
“adriamycin nephropathy group (sick group)” and “Zhenwutang
treatment group (treated group)” were prepared for detection and
analysis. Urinary sample solutions were injected into the micro-
ﬂuidic chip (Fig. 2b) via an electronic-controlled pump, eliminat-
ing potential environmental effects (strain, pressure, bending,
humidity, etc.).
The plasmonic TFBG sensing probe was excited by a broadband
light source (BBS) launched in the ﬁber core covering the spectral
region from 1440 to 1560 nm, and its transmission spectrum
monitored by an optical spectrum analyzer (OSA) with minimum
wavelength resolution of 0.02 nm. A linear polarizer and polar-
ization controller (PC) were placed upstream of the TFBG probe to
adjust and orient the state of polarization of the light launched
into ﬁber grating so as to provide the strongest SPR excitation, i.e.
selective excitation of cladding modes with almost 100% radially
polarized light at the cladding surface, i.e. perpendicular to the
metal surface.3. Plasmonic TFBG sensor
3.1. Fabrication of TFBG
The TFBG sensor (15 mm in length) was manufactured using
the phase-mask technique in a commercial single-mode ﬁber
(Fig. 3a). The fabrication process mainly includes the following
three steps. Firstly, the ﬁber was hydrogen-loaded (temperature:
50 °C, pressure: 1500 psi, loading time: 168 h) to increase the
photosensitivity of the ﬁber core. Secondly, pulsed 193 nm UV
light (power of 3 mJ per pulse, frequency of 200 Hz) was focused
with a cylinder lens and scanned over the ﬁber region. The phaseSensor
Micro-fluidic chip
Ag-TFBG
OSA
Pump in Pump out
Fiber Sensor embedded
ncentration of proteins; (b) micro-ﬂuidic chip for urinary samples measurement.
Fig. 3. Schematics of (a) TFBG inscription system and (b) surface nanometric-coating system ((I) ﬁber rotated instead of ﬁxed and (II) photograph of uniform Ag coating).
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to induce a periodical effective refractive index modulation in the
ﬁber core. Finally, by rotating the phase mask and the ﬁber (inset
of Fig. 3a) simultaneously, a selectable tilt angle (relatively to the
longitudinal axis of the ﬁber) can be easily induced into the
grating. The tilt of the grating is an important parameter that can
be used to choose which set of cladding modes is to be excited. As
a result, it makes it possible to adjust the operating range of the
sensor in order to optimize the response for certain refractive in-
dices. Here, the tilt angle of TFBG was selected to be 20 °, which
provides the maximal amplitude of cladding modes for aqueous
solutions measurement (RI range of 1.32–1.35).
3.2. Ultra-thin metallic coating
A ultra-thin silver ﬁlm was deposited on the ﬁber probe using
the sputtering technique (RF magnetron sputtering). To achieve a
high quality coating, two issues must be noted. One is to improve
the ﬁlm's adhesion. Here we use a 2–3 nm thickness of chromium
sandwiched between the optical ﬁber surface and the silver ﬁlm.
The second is to ensure a uniform thickness of silver ﬁlm over the
whole ﬁber surface. Traditional ﬂat-plane sputtering technique is
not ﬁt for the small diameter cylindrical ﬁber because sputtering is
directional from the ﬁxed target. To avoid thickness non-
uniformities, during the sputtering process the ﬁber was rotated
along its axis (Fig. 3a). With this design, we can ensure a very
uniform nanometric coating over ﬁber surface (Fig. 3b).
3.3. Hybrid plasmonic and cut-off resonances excitations
The key point of achieving differential spectral changes be-
tween the SPR mode and a near cut-off cladding mode with a
single coated TFBG is to choose a proper thickness of the nano-
metric-coating. Fig. 4 shows the schematic diagrams and spectral
characteristics of the same TFBG with different thicknesses of Ag
on its surface with: no coating, 20–30 nm and 50 nm Ag-coating
respectively. We will show in the next paragraphs how the dif-
ferent coating thicknesses lead to different sensing characteristics.
Note that all the spectra shown in Fig. 4 are measured from the
same TFBG in the same water solution (RI¼1.332).
For the bare TFBG (Fig. 4a), the surrounding RI measurement is
based on evanescent wave (EW) of cladding modes. Beside the
core mode located at the longest wavelength (immune to sur-
rounding RI), there are hundreds of cladding-guided resonances
with high sensitivity to surrounding RI and tens of leaky modes
with effective indices larger than the surrounding RI. The bound-
ary between cladding and leaky modes is indicated by a suddenincrease in the loss of the modes, evidenced by reduced amplitude
of the cladding mode resonance (the red asterisk “*” marked in
Fig. 4a). The most sensitive cladding mode is the last one re-
maining guided for a given surrounding RI because it is the mode
with the largest penetration outside the ﬁber (Guo et al., 2014).
For the “thick” Ag-coating TFBG (Fig. 4c), the surrounding RI
measurement is based on the excitation of a surface plasmon wave
(SPW). In TFBGs, when linearly polarized light is launched with its
polarization parallel to the tilt plane (P-polarized), the electric ﬁeld
of the cladding modes is nearly 100% polarized in the radial di-
rection, i.e. in the TM polarization relative to the metal coating.
Evidence of SPR in the spectrum for this polarization is the dis-
appearance of the cladding mode resonances near 1490 nm due to
the coupling of the cladding mode energy to the very lossy SPW at
these wavelengths. This coupling is maximized for thicknesses
near 50 nm. When the other direction of the input polarized light
is used, i.e. the S-polarization, the electric ﬁeld is aligned in the TE
direction with the ﬁber surface and no SPR can occur. Using the
TM spectrum, the ﬁne comb of narrowband resonances of the
TFBG provides a unique tool to measure small shifts of the plas-
mon with high accuracy. This is accomplished by choosing a re-
sonance on the short wavelength side of the maximum SPR at-
tenuation (the red asterisk “*” marked in Fig. 4c, named plasmonic
resonance). The shift of the SPR can be easily measured by mon-
itoring the amplitude change of the chosen resonance, as it in-
creases when the SPR moves away (towards longer wavelengths
when the surrounding RI increases) or decreases when the SPR
approaches in response to a decreasing RI (Caucheteur et al., 2013).
Finally, the “thin” Ag-coating TFBG (Fig. 4b) provides a trade-off
condition to combine the two methodologies in a single device.
Through experiments with ﬁbers coated by various thicknesses
between 0 and 50 nm, it was found that the 20–30 nm thickness
range can support a slightly weakened SPR excitation and that it
also allows some cladding modes near cut-off to tunnel across the
metal ﬁlm (two modes identiﬁed by red asterisks “*” in Fig. 4b).
Because both of these two resonances show extremely high RI
sensitivities but inverse amplitude responses to the surrounding RI
(Section 4 makes this determination clear), such ultra-thin coating
design will further improve the limit of detection by using a dif-
ferential amplitude measurement instead of an absolute one.4. Results and discussion
Fig. 5 presents the spectral response of the experimental tests
and corresponding data analysis. The proposed biosensor shows a
quick response (1.0 s per full scan by the OSA) and clearly
Fig. 4. Spectral characteristics of TFBG (20o tilted angle) versus different thickness of nanometric-coating: (a) bare TFBG without Ag-coating (a clear cut-off resonance at the
boundary between guided modes (at longer wavelength side) and leaky modes (at shorter wavelength side)); (b) TFBG with 20–30 nm Ag-coating (hybrid “cut-off” and
“plasmonic” resonances achieved simultaneously over a single TFBG); (c) TFBG with 50 nm Ag-coating (the normal thickness range for “plasmonic” excitation without leaky
modes (at shorter wavelength side)). Note: red stars mark the corresponding position of “cut-off” and “plasmonic” resonances; P and S polarizations corresponds to two
orthogonal polarizations in which SPR excitation over the P polarization; All above transmission spectra are measured from one TFBG in the same water solution (RI¼1.332).
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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“healthy group”, “sick group” and “treated group”.
In more detail, Fig. 5a shows the whole transmission spectra of
the sensor. It provides two important pieces of information: one is
that very small surrounding RI perturbations induce signiﬁcant
changes in the cladding mode resonances (such changes could
arise from bulk medium changes, thickness changes in an adlayer,
or molecular binding events for functional layers attached to themetal surface). The other is the temperature self-calibration ability
indicated by the unchanged core mode (where spectral shifts due
to temperature changes can be eliminated by referencing all wa-
velengths to the core mode, which is unaffected by the sur-
rounding RI and has the same temperature dependence with the
other modes, thereby ensuring that the differential spectra are due
solely to surrounding RI changes or different bio-sample
solutions).
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cut-off resonance and of the plasmonic resonance. Obviously, both
of these resonances show high sensitivity (several dB of change)
but inverse amplitude responses to the near surface RI. As already
brieﬂy mentioned, when the surrounding RI increases, the SPR
attenuation shifts towards the longer wavelength side and the
marked plasmonic resonance amplitude recovers to its original
“sharp” state so as to get stronger. The cut-off resonance however
decreases its amplitude because the surrounding RI increase
brings the resonance even closer to cut off and therefore decreases
its amplitude. By using a differential amplitude monitoring be-
tween cut-off and plasmonic resonances (Fig. 5c), the effect of
proteins in the urine of rats with different concentrations (related
to the “healthy”, “sick” and “treated” rat groups) and corre-
sponding RI ranging from 1.3400 to 1.3408 (the refractive indices
of the solutions were measured at a wavelength of 589 nmwith an
Abbe refractometer) were clearly discriminated in-situ with an
amplitude variation sensitivity of 8100 dB/RIU and a limit of de-
tection of 105 RIU (the refractive indices at the wavelength of
operation of the sensor are different but this has no impact on the
measurement, following sensor calibration for a given applica-
tion). Repeat measurements were used to identify these perfor-
mance indicators with a relative standard deviation (RSD) of less
than 15% (the average and error bars shown in Fig. 5c were de-
termined from three measurements of 30 samples (10 samples for
each group)).
Our method has also been compared with the traditional BCA
method (in which the concentration of proteins is determined by
the amount of light absorption at 562 nm, named as optical den-
sity (OD), arising from the reaction of proteins in copper salt so-
lutions), for which all the experimental conditions used are the
same. The BCA results (red triangle data) shown in Fig. 5d provide
the measurement of the total concentration of the protein in the
rat urine samples and with these data a standard curve of the
whole protein concentration can be achieved (black line). Such
standard curve is necessary for the calibration of the ﬁber result
(i.e. refractive index change vs. protein concentration, using the
three ﬁber-optic measurements (the colored circle points marked
in Fig. 5d)). Calibrated with the traditional BCA method (Fig. 5d),
our proposed plasmonic ﬁber-optic sensor provides an protein
concentration sensitivity of 5.5 dB/(mg/ml) and a limit of detection
of 1.5103 mg/ml.5. Conclusions
In summary, the feasibility of highly sensitive detection of
proteinuria using plasmonic tilted ﬁber grating sensors with ultra-
thin nanometric-coating has been demonstrated. By using a dif-
ferential amplitude monitoring between the plasmonic and cut-off
resonances, a protein concentration sensitivity of 5.5 dB/(mg/ml)
and a limit of detection of 1.5103 mg/ml have been achieved.
The intrinsic relationship between the outﬂow of protein and RI
variation in urine has been demonstrated, which helps to the
evaluation and development of new drugs for nephropathy
treatment. The detection process was precisely controlled with a
micro-ﬂuidic chip which allows the measurement work on sub-
microliter dose of bio-sample solutions. For bio-chemical appli-
cations with high speciﬁcity, the nanometric-coated TFBG can be
used for label-free sensing when provided with a functionalized
coating whose RI can be modiﬁed by the selective attachment of
certain types of molecules or cells. The sensor can operate in re-
ﬂection (instead of transmission) with a cleaved end downstream
of the grating and with gold or silver coating on the face of the
cleave. It makes the length of the entire sensor “head” very small
(as little as 10 to 20 mm) so that the sensing probe can be easilyinserted into the media to be sensed. The proposed in-ﬁber plas-
monic biosensor shows a minimal cross-sensitivity to temperature
and its fabrication does not impact the structural integrity of the
ﬁber, makes it an appealing solution for rapid, low consumption
and highly sensitive detection of analytes at low concentrations in
medicine, chemical and environmental monitoring.Acknowledgments
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